J+D FORECASTING LAUNCHES A SEAMLESS PHARMACEUTICAL FORECASTING SOLUTION
J+D Forecasting, one of the world’s leading pharmaceutical forecasting companies, has today announced the launch of Onco+, as the latest addition to its comprehensive suite of forecasting software.
FC365 is an intelligent, innovative, cloud-based solution for global forecasting teams
J+D Forecasting, one of the world’s leading pharmaceutical forecasting companies, has today announced the launch of FC365, the latest addition to its comprehensive suite of bespoke forecasting solutions and syndicated software.
FC365, has been specifically created to introduce improved efficiencies, greater accuracy and better collaboration across global teams involved in the creation of pharmaceutical forecasts. Clients benefit from decades of J+D’s pharmaceutical modelling training and change management expertise. In addition, FC365 incorporates a powerful combination of Excel, SharePoint, Power Automate and PowerBI technologies
FC365 is the only solution of this kind specifically created for the pharmaceutical industry. Forecast models can be updated quickly and easily and are all held in one central ‘control’ point. Processes are automated to speed up the entire review processes and changes can be made in real time. Ultimately users benefit from a streamlined, instant forecasting process with interactive dashboards and automated PowerPoint charting functionality.
David James, CEO at J+D Forecasting, said:
“FC365 helps our clients step back to explore more strategic opportunities across the organisation. Our hands-on consultative approach combined with existing Microsoft technology affords our clients the time and space to concentrate on outputs that matter.
Over the years we’ve developed strategic forecasting platforms for some of the biggest names in the pharma industry and have used this vast experience and knowledge to develop FC365, a seamless approach to global pharmaceutical forecasting. One of our clients believes this has changed their forecasting life forever!”